Results 161 to 170 of about 58,392 (301)

New Bifunctional Chelator 3p-C-NEPA for Potential Applications in Lu(III) and Y(III) Radionuclide Therapy and Imaging [PDF]

open access: gold, 2020
Xiang Sun   +8 more
openalex   +1 more source

Advancing Tuberculosis Chemotherapy: Targeted Nanomedicines for the Mycobacterium TB Granuloma

open access: yesSmall, Volume 21, Issue 49, December 10, 2025.
This graphical abstract illustrates nanosystems used for targeted drug delivery into tuberculosis granulomas. It shows how targeting is influenced by size, pH, redox sensitivity, and surface charge. Various nanoparticles are incorporated with drugs to enhance penetration, stability, and release.
Shreya Ranjith Singh   +3 more
wiley   +1 more source

RADIATION-HYGIENIC JUSTIFICATION OF OUTPATIENT RADIONUCLIDE THERAPY

open access: yesРадиационная гигиена, 2015
The possibility of the use of the different therapeutic radiopharmaceuticals labeled with one of the 19 β-γ-emitting radionuclides or 6 α-β-γ-emitting radionuclides in the outpatient regime was identified in the estimateinvestigations.
B. Ja. Narkevich   +4 more
doaj  

Liposomal 188Rhenium Plus Macrophage Depletion Enhances Anti‐PD‐L1 Efficacy and B Cell Infiltration Against Lung Metastatic Cancer

open access: yesCancer Science, Volume 116, Issue 12, Page 3442-3458, December 2025.
This study demonstrates that combining liposomal Rhenium‐188 (Lipo‐Re188) with macrophage depletion and anti–PD‐L1 therapy enhances therapeutic efficacy against lung metastatic colon cancer. The triple therapy promotes B cell infiltration, restores T cell function, and suppresses MDSC, creating a tumor‐suppressive immune microenvironment.
Shin‐Yi Liu   +3 more
wiley   +1 more source

Patient organ and effective dose estimation in radionuclide therapy with <sup>223</sup>Ra -dichloride

open access: diamond, 2020
Л. А. Чипига   +8 more
openalex   +2 more sources

Supplementary Figure from Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177–Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model

open access: gold, 2023
Thomas Ertveldt   +14 more
openalex   +1 more source

Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms

open access: yesJournal of Neuroendocrinology, Volume 37, Issue 12, December 2025.
Abstract Neuroendocrine neoplasms (NEN) themselves and also their treatment may cause malnutrition, inducing changes in physiological behaviour and eventually leading to increased rates of morbidity and mortality. Malnutrition is a common, under‐recognised and under‐treated condition in patients with NEN, and there are limited data available on the ...
Simona Grozinsky‐Glasberg   +53 more
wiley   +1 more source

Home - About - Disclaimer - Privacy